Stenocare A/S

CPSE:STENO Stock Report

Market Cap: DKK 26.4m

Stenocare Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Thomas Schnegelsberg

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.2yrs
CEO ownershipn/a
Management average tenure7.2yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

Is Stenocare (CPH:STENO) In A Good Position To Deliver On Growth Plans?

Mar 29
Is Stenocare (CPH:STENO) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Stenocare's (CPH:STENO) Cash Burn Rate

Nov 29
We're Keeping An Eye On Stenocare's (CPH:STENO) Cash Burn Rate

Is Stenocare (CPH:STENO) In A Good Position To Deliver On Growth Plans?

Apr 02
Is Stenocare (CPH:STENO) In A Good Position To Deliver On Growth Plans?

Is Stenocare (CPH:STENO) In A Good Position To Invest In Growth?

Dec 18
Is Stenocare (CPH:STENO) In A Good Position To Invest In Growth?

CEO

Thomas Schnegelsberg (59 yo)

7.2yrs

Tenure

Mr. Thomas Skovlund Schnegelsberg serves as Chief Executive Officer since October 2017 and Co-Founder of Stenocare A/S. Mr. Schnegelsberg serves as Deputy Chairman of Bagsværd Kost- & Gymnasium Skole. Mr....

Leadership Team

NamePositionTenureCompensationOwnership
Thomas Schnegelsberg
CEO, Co-Founder & Member of Executive Board7.2yrsno datano data
Rolf Petersen
Co-Founderno datano data8.37%
DKK 2.2m
Soren Kjaer
Co-Founder7.9yrsno datano data
Peter Johansen
Chief Financial Officer6.3yrsno datano data

7.2yrs

Average Tenure

59.5yo

Average Age

Experienced Management: STENO's management team is seasoned and experienced (7.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Rolf Petersen
Co-Founderno datano data8.37%
DKK 2.2m
Soren Kjaer
Co-Founderno datano datano data
Jeppe Petersen
Independent Director6.3yrsno datano data
Marianne Wier
Non Executive Independent Chairman6.3yrsno datano data
Soren Frederiksen
Independent Director6.3yrsno datano data

6.3yrs

Average Tenure

59yo

Average Age

Experienced Board: STENO's board of directors are considered experienced (6.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 09:24
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Stenocare A/S is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution